SOFLENS66(TM)

FDA Premarket Approval P960022

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the bausch & lomb(r) soflens66(tm) (alphafilcon a) visibility tinted contact lens for extended wear.

DeviceSOFLENS66(TM)
Generic NameLenses, Soft Contact, Extended Wear
ApplicantBausch & Lomb, Inc.
Date Received1996-06-28
Decision Date1996-12-16
Notice Date1997-05-22
PMAP960022
SupplementS
Product CodeLPM 
Docket Number97M-0183
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address Bausch & Lomb, Inc. 1400 North Goodman St. rochester, NY 14609-3547

Supplemental Filings

Supplement NumberDateSupplement Type
P960022Original Filing
S012 2020-03-20 30-day Notice
S011 2015-09-29 30-day Notice
S010 2013-10-17 30-day Notice
S009 2011-10-19 135 Review Track For 30-day Notice
S008 2011-03-03 30-day Notice
S007 2010-11-15 Normal 180 Day Track No User Fee
S006 2010-05-17 30-day Notice
S005 2008-09-24 Real-time Process
S004 2004-02-06 30-day Notice
S003 2003-03-03 Real-time Process
S002 2001-01-09 Normal 180 Day Track
S001 1997-08-07 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.